Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$1.12 USD
-0.08 (-6.67%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Earnings News For GANX
-
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
-
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
-
Gain Therapeutics, Inc. (GANX) Reports Q2 Loss, Misses Revenue Estimates
-
Gain Therapeutics, Inc. (GANX) Reports Q1 Loss, Tops Revenue Estimates
-
Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update
-
Analysts Estimate Gain Therapeutics, Inc. (GANX) to Report a Decline in Earnings: What to Look Out for
-
Gain Therapeutics, Inc. (GANX) Reports Q3 Loss, Lags Revenue Estimates
-
Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update
-
Gain Therapeutics, Inc. (GANX) Reports Q2 Loss, Tops Revenue Estimates
-
Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update
-
Gain Therapeutics, Inc. (GANX) Expected to Beat Earnings Estimates: Should You Buy?
-
Gain Therapeutics, Inc. (GANX) Reports Q1 Loss, Misses Revenue Estimates
-
Gain Therapeutics, Inc. (GANX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?